Apellis Pharmaceuticals, Inc

(NASDAQ:APLS)

Latest On Apellis Pharmaceuticals, Inc (APLS):

Date/Time Type Description Signal Details
2023-05-25 17:48 ESTNewsApellis and Sobi to drop ALS candidate on Phase 2 setbackN/A
2023-05-18 17:01 ESTNewsApellis Pharmaceuticals: Biotech's Rising Star In C3 Inhibition SpaceN/A
2023-05-06 12:27 ESTNewsApellis Pharmaceuticals, Inc. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-06 12:27 ESTNewsApellis Pharmaceuticals, Inc. (APLS) Q1 2023 Earnings Call TranscriptN/A
2023-05-04 22:14 ESTNewsApellis Pharmaceuticals: Maintain 'Buy' Following Astellas' $5.9 Billion Acquisition Of Iveric BioN/A
2023-05-04 22:14 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.56 misses by $0.10, revenue of $44.84M beats by $18.74MN/A
2023-05-03 20:58 ESTNewsApellis Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-05-01 19:14 ESTNewsApellis weakness on Iveric Bio takeout is buying opportunity - analystN/A
2023-05-01 06:55 ESTNewsApellis Pharmaceuticals (APLS) Presents at the Association for Research in Vision and Ophthalmology Annual Meeting - SlideshowN/A
2023-04-03 17:26 ESTNewsApellis Pharmaceuticals may be worth $90-$100 a share in sale - analystN/A
2023-04-02 23:22 ESTNewsApellis Pharmaceuticals sees takeover interest from large pharma - BloombergN/A
2023-03-24 22:48 ESTNewsApellis Pharmaceuticals Is Poised For Dominance In Geographic Atrophy MarketN/A
2023-03-16 14:19 ESTNewsApellis Pharmaceuticals' Empaveli sNDA action date extended by FDAN/A
2023-02-23 11:44 ESTNewsApellis Pharmaceuticals prices $350M in stock offeringN/A
2023-02-22 09:58 ESTNewsApellis Pharmaceuticals to raise $300M in stock and warrants offeringN/A
2023-02-21 21:29 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.50 beats by $0.06, revenue of $22.66M misses by $1.86MN/A
2023-02-18 02:43 ESTNewsApellis wins FDA nod for eye disorder therapyN/A
2023-01-27 18:43 ESTNewsApellis: Empaveli Ought To Win Approval For Eye Disease In February - The Future Looks BrightN/A
2023-01-21 14:26 ESTNewsStocks To Watch: Earnings Heat Up, Healthcare Catalysts And M&A WildcardsN/A
2023-01-05 20:02 ESTNewsApellis appoints Baumal as Chief Medical OfficerN/A
2023-01-04 02:30 ESTNewsApellis, Arvinas lower as Wells Fargo downgrades in 2023 biotech previewN/A
2022-12-15 23:44 ESTNewsApellis Pharmaceuticals: Approval Is Baked Into ValuationN/A
2022-11-18 10:24 ESTNewsApellis surges 17% as FDA accepts to review new data in filing for eye disorder drugN/A
2022-11-11 06:07 ESTNewsApellis, IVERIC bio cut to Hold at Jefferies; says Street overestimates GA marketN/A
2022-11-08 08:01 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.75 misses by $0.29, revenue of $22.05M beats by $0.46MN/A
2022-11-08 08:00 ESTNewsApellis Pharmaceuticals, Inc. (APLS) Q3 2022 Earnings Call TranscriptN/A
2022-11-05 08:22 ESTNewsApellis Pharmaceuticals Q3 2022 Earnings PreviewN/A
2022-11-03 23:08 ESTNewsApellis sinks 20% as FDA review period for eye disease drug extendsN/A
2022-10-16 23:00 ESTNewsCiti lists four more value-creating events in biotech for this yearN/A
2022-09-29 06:33 ESTNewsApellis Pharmaceuticals: Trying To Develop A Blockbuster FranchiseN/A
2022-09-08 07:22 ESTNewsApellis gains as FDA says AdCom unnecessary for eye disease candidateN/A
2022-08-24 16:51 ESTNewsApellis stock dips amid 2-year data of pegcetacoplan for eye disorderN/A
2022-08-09 18:37 ESTNewsApellis Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-09 18:37 ESTNewsApellis Pharmaceuticals, Inc. (APLS) CEO Cedric Francois on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-08 18:56 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.46 misses by $0.09, revenue of $16.32M misses by $0.63MN/A
2022-08-06 06:05 ESTNewsApellis Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-07-27 15:50 ESTNewsApellis to exchange $75.6M in convertible senior notes for common stockN/A
2022-07-20 18:36 ESTNewsApellis Pharmaceuticals: The Meaning Of Priority Review For Pegcetacoplan For Geographic AtrophyN/A
2022-07-20 03:57 ESTNewsWainwright sees blockbuster potential for Apellis eye degeneration therapy; shares up 22%N/A
2022-07-19 13:21 ESTNewsApellis stock soars 24% as FDA grants priority review to pegcetacoplan for eye disorderN/A
2022-07-19 13:19 ESTNewsH.C. Wainwright sees blockbuster potential for Apellis' treatment in eye degenerationN/A
2022-06-25 15:25 ESTNewsApellis: Mixed Data, But Definitely Approvable In GAN/A
2022-06-13 19:55 ESTNewsHot Stocks: APLS & SKIL both gain, TSLA declined despite upgrade, and VLTA plungedN/A
2022-06-10 11:34 ESTNewsApellis/Sobi Empaveli shows benefit in rare blood disorder patients in new analysesN/A
2022-06-01 11:05 ESTNewsApellis files for FDA approval of pegcetacoplan to treat eye disorderN/A
2022-05-06 19:17 ESTNewsApellis Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-06 19:15 ESTNewsApellis Pharmaceuticals (APLS) Investor Presentation - SlideshowN/A
2022-05-04 22:43 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.42 misses by $0.12, revenue of $12.1M misses by $0.52MN/A
2022-05-04 22:42 ESTNewsApellis Pharmaceuticals, Inc. (APLS) CEO Cedric Francois on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 03:15 ESTNewsApellis Pharmaceuticals Q1 2022 Earnings PreviewN/A

About Apellis Pharmaceuticals, Inc (APLS):

Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. Its lead product candidate is pegcetacoplan that is in Phase III clinical trials for the treatment of geographic atrophy in age-related macular degeneration and paroxysmal nocturnal hemoglobinuria (PNH) diseases; cold agglutinin disease; C3 glomerulopathy; and other glomerular diseases, such as IgA nephropathy, primary membranous nephropathy, and lupus nephritis. The company also develops APL-9, which is in single ascending dose Phase I randomized, double-blind, and placebo-controlled clinical trials for the prevention of immune system activation coincident with adeno-associated virus for intravenous administration, as well as is in Phase I/II clinical trial for acute respiratory distress syndrome. It has a collaboration and license agreement with Swedish Orphan Biovitrum AB (publ) to co-develop pegcetacoplan. The company was incorporated in 2009 and is based in Waltham, Massachusetts.

See Advanced Chart

General

  • Name Apellis Pharmaceuticals, Inc
  • Symbol APLS
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 374
  • Fiscal Year EndDecember
  • IPO Date2017-11-09
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.apellis.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 13.99
  • Price/Book (Most Recent Quarter) 18.33
  • Enterprise Value Revenue 12.97
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$6.46
  • Next Year EPS Estimate -$5.31
  • Next Quarter EPS Estimate -$1.60
  • Profit Margin -138%
  • Operating Margin -85%
  • Return on Assets -20%
  • Return on Equity -289%
  • Revenue 250.65 million
  • Earnings Per Share -$3.32
  • Revenue Per Share $3.34
  • Gross Profit -74325000
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 3.54 billion
  • Analyst Target Price $64.14
  • Book Value Per Share $2.69
View More

Share Statistics

  • Shares Outstanding 80.38 million
  • Shares Float 59.7 million
  • % Held by Insiders 2117%
  • % Held by Institutions 82.85%
  • Shares Short 8.11 million
  • Shares Short Prior Month 7.75 million
  • Short Ratio 13.44
  • Short % of Float 15%
  • Short % of Shares Outstanding 10%
View More

Technicals

  • Beta 1.52
  • 52 Week High $58.47
  • 52 Week Low $21.84
  • 50 Day Moving Average 46.47
  • 200 Day Moving Average 42.62
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Apellis Pharmaceuticals, Inc (APLS) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Apellis Pharmaceuticals, Inc (APLS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A$0.93-$0.45304.58%
2020-09-302020-11-02$646000-$1.79-$1.58-13.31%
2020-06-302020-07-30$N/A-$1.57-$1.34-17.56%
2020-03-312020-04-29$N/A-$2.29-$1.39-64.72%
2019-12-312020-02-27$N/A-$1.77-$1.14-55%
2019-09-302019-11-05$N/A-$1.10-$1.03-6.44%
2019-06-302019-07-31$N/A-$1.12-$0.78-44.39%
2019-03-312019-05-07$N/A-$0.87-$0.68-27.49%
2018-12-312019-02-26$N/A-$0.65-$0.707.58%
2018-09-302018-11-13$N/A-$0.64-$0.697.02%
2018-06-302018-07-31$N/A-$0.61-$0.42-45.86%
2018-03-312018-04-30$N/A-$0.43-$0.27-57.28%
2017-12-312018-03-19$N/A-$0.61-$0.27-129.32%
2017-09-302017-12-20$N/A-$0.23-$0.242.75%

Apellis Pharmaceuticals, Inc (APLS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Apellis Pharmaceuticals, Inc (APLS) Chart:

Apellis Pharmaceuticals, Inc (APLS) News:

Below you will find a list of latest news for Apellis Pharmaceuticals, Inc (APLS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Apellis Pharmaceuticals, Inc (APLS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-11-21110CALL0 00TRUE00
2025-11-21120CALL0 00TRUE00
2025-11-21130CALL0 070.67TRUE00
2025-11-21140CALL0 00TRUE00
2025-11-21158.2CALL0 300TRUE00
2025-11-21160CALL0 00TRUE00
2025-11-21170CALL0 00TRUE00
2025-11-21182.75CALL7 1063.68TRUE-1.05-0.28
2025-11-21190CALL0 046.44TRUE00
2025-11-21201.7CALL17 035.98TRUE1.70
2025-11-21211.25CALL83 948.98TRUE-0.05-0.04
2025-11-21221.1CALL598 8365.5FALSE0.110.11
2025-11-21230.65CALL49 45260.49FALSE-0.15-0.19
2025-11-21240.48CALL1 48065.14FALSE-0.37-0.44
2025-11-21250.32CALL65 41866.43FALSE-0.15-0.32
2025-11-21260.25CALL10 13071.1FALSE-0.25-0.5
2025-11-21270.16CALL27 5471.26FALSE-0.54-0.77
2025-11-21280.05CALL8 25762.25FALSE-0.17-0.77
2025-11-21290.2CALL0 63114.99FALSE00
2025-11-21300.08CALL33 61281.58FALSE-0.02-0.2
2025-11-21310.08CALL22 28087.81FALSE-0.62-0.89
2025-11-21320.15CALL0 21162.15FALSE00
2025-11-21331.37CALL0 104196.88FALSE00
2025-11-21340.45CALL0 15176.96FALSE00
2025-11-21350.02CALL0 26183.86FALSE00
2025-11-21360CALL0 0205.17FALSE00
2025-11-21370CALL0 0211.7FALSE00
2025-11-21380CALL0 0217.97FALSE00
2025-11-21390CALL0 0224FALSE00
2025-11-21400.3CALL0 10247.43FALSE00
2025-11-21410CALL0 0276.01FALSE00
2025-11-21110PUT0 0220.02FALSE00
2025-11-21120PUT0 0330.87FALSE00
2025-11-21130PUT0 0298.23FALSE00
2025-11-21140PUT0 0272.14FALSE00
2025-11-21150.05PUT0 1174.57FALSE00
2025-11-21160PUT0 0152.76FALSE00
2025-11-21170.11PUT2 2170.73FALSE-0.14-0.56
2025-11-21180.49PUT6 5792.61FALSE0.393.9
2025-11-21190.55PUT4 2060.61FALSE0.250.83
2025-11-21200.55PUT513 4159.57FALSE-0.05-0.08
2025-11-21210.95PUT0 9665.17FALSE00
2025-11-21221.6PUT21 25866.26TRUE-0.3-0.16
2025-11-21232.1PUT2 7258.58TRUE-0.3-0.13
2025-11-21244PUT20 3474.67TRUE0.760.23
2025-11-21254.9PUT3 113130.99TRUE1.70.53
2025-11-21260PUT0 097.82TRUE00
2025-11-21276.22PUT4 404116.44TRUE0.810.15
2025-11-21287.17PUT0 30TRUE00
2025-11-21294.72PUT0 287.24TRUE00
2025-11-21309.28PUT2 305149.38TRUE0.150.02
2025-11-21314.36PUT0 10TRUE00
2025-11-21320PUT0 0108.07TRUE00
2025-11-21330PUT0 092.82TRUE00
2025-11-21340PUT0 098.18TRUE00
2025-11-21350PUT0 00TRUE00
2025-11-21360PUT0 0108.32TRUE00
2025-11-21370PUT0 00TRUE00
2025-11-21380PUT0 0150.39TRUE00
2025-11-21390PUT0 0147.46TRUE00
2025-11-21400PUT0 0142.12TRUE00
2025-11-21410PUT0 0146.66TRUE00
2025-12-19110CALL0 00TRUE00
2025-12-19120CALL0 00TRUE00
2025-12-19130CALL0 076.24TRUE00
2025-12-19140CALL0 00TRUE00
2025-12-19150CALL0 063.41TRUE00
2025-12-19160CALL0 081.69TRUE00
2025-12-19170CALL0 037.01TRUE00
2025-12-19183.8CALL1 046.27TRUE3.80
2025-12-19190CALL0 064.04TRUE00
2025-12-19202.15CALL15 040.15TRUE2.150
2025-12-19213.35CALL0 156.16TRUE00
2025-12-19221.6CALL15 1357.45FALSE-0.1-0.06
2025-12-19232CALL0 162.5FALSE00
2025-12-19241.6CALL0 862.89FALSE00
2025-12-19250.7CALL1 1272.83FALSE-0.55-0.44
2025-12-19261.2CALL5 084.64FALSE1.20
2025-12-19270.76CALL0 468.7FALSE00
2025-12-19280.5CALL0 589.73FALSE00
2025-12-19291.51CALL0 192.01FALSE00
2025-12-19303.4CALL0 16100FALSE00
2025-12-19310.05CALL0 399FALSE00
2025-12-19320CALL0 0104.16FALSE00
2025-12-19330CALL0 0109.07FALSE00
2025-12-19340CALL0 0113.74FALSE00
2025-12-19351.4CALL0 60138.31FALSE00
2025-12-19360CALL0 0131.95FALSE00
2025-12-19370CALL0 0138.44FALSE00
2025-12-19380CALL0 0142.52FALSE00
2025-12-19390.25CALL0 10146.45FALSE00
2025-12-19400CALL0 0150.23FALSE00
2025-12-19410CALL0 0153.87FALSE00
2025-12-19450CALL0 0174.37FALSE00
2025-12-19110PUT0 0230.64FALSE00
2025-12-19120PUT0 0208.1FALSE00
2025-12-19130PUT0 0147.34FALSE00
2025-12-19140PUT0 0186.89FALSE00
2025-12-19150PUT0 0140.47FALSE00
2025-12-19160PUT0 0129.09FALSE00
2025-12-19170PUT0 079.45FALSE00
2025-12-19180PUT0 058.37FALSE00
2025-12-19191.5PUT1 062.79FALSE1.50
2025-12-19200PUT0 062.98FALSE00
2025-12-19210PUT0 069.43FALSE00
2025-12-19221.97PUT0 466.42TRUE00
2025-12-19230.55PUT0 463.49TRUE00
2025-12-19240PUT0 076.62TRUE00
2025-12-19251.45PUT0 168.67TRUE00
2025-12-19264PUT0 071.14TRUE00
2025-12-19275.42PUT0 165.62TRUE00
2025-12-19280PUT0 078.88TRUE00
2025-12-19292.55PUT0 466.89TRUE00
2025-12-19300PUT0 072.13TRUE00
2025-12-19310PUT0 086.16TRUE00
2025-12-19320PUT0 069.08TRUE00
2025-12-19330PUT0 065.82TRUE00
2025-12-19340PUT0 097.41TRUE00
2025-12-19350PUT0 0101.71TRUE00
2025-12-19360PUT0 098.81TRUE00
2025-12-19379.5PUT0 10102.66TRUE00
2025-12-19380PUT0 0106.36TRUE00
2025-12-19390PUT0 0113.8TRUE00
2025-12-19400PUT0 0113.42TRUE00
2025-12-19410PUT0 0101.36TRUE00
2025-12-19450PUT0 0119.43TRUE00
2026-01-16100CALL0 00TRUE00
2026-01-16110CALL0 00TRUE00
2026-01-161216.66CALL0 10TRUE00
2026-01-16130CALL0 869.53TRUE00
2026-01-16140CALL0 059.97TRUE00
2026-01-16158CALL0 4170.02TRUE00
2026-01-16165CALL0 267.88TRUE00
2026-01-161710.09CALL0 5962.11TRUE00
2026-01-16183.8CALL7 14134.2TRUE3.80
2026-01-16199.45CALL0 2769.02TRUE00
2026-01-16203.3CALL10 1046163.86TRUE0.10.03
2026-01-16213.8CALL0 12860.89TRUE00
2026-01-1622.52.2CALL29 158065.44FALSE-0.1-0.04
2026-01-16247.72CALL0 20852.1FALSE00
2026-01-16251.49CALL62 405467.99FALSE0.040.03
2026-01-16261.8CALL0 44364.61FALSE00
2026-01-16271.4CALL0 56359.14FALSE00
2026-01-16285.05CALL0 1861.87FALSE00
2026-01-16291.9CALL0 35558.18FALSE00
2026-01-16300.55CALL11 172466.52FALSE-0.25-0.31
2026-01-16312.74CALL0 77126.21FALSE00
2026-01-16321.25CALL0 4289.43FALSE00
2026-01-16330.81CALL0 2389.94FALSE00
2026-01-16341.1CALL0 30790FALSE00
2026-01-16350.35CALL0 1610100.96FALSE00
2026-01-16360CALL0 0104.47FALSE00
2026-01-16370CALL0 0107.83FALSE00
2026-01-16380CALL0 0111.06FALSE00
2026-01-16390CALL0 0106.36FALSE00
2026-01-16400.13CALL25 1049173.67FALSE-0.01-0.07
2026-01-16410CALL0 0112.06FALSE00
2026-01-16450.42CALL0 43672.9FALSE00
2026-01-16500.05CALL0 360126.48FALSE00
2026-01-16550.95CALL0 171152.28FALSE00
2026-01-16602.05CALL0 1182152.19FALSE00
2026-01-16650.1CALL0 271160.03FALSE00
2026-01-16700.14CALL0 343139.28FALSE00
2026-01-16750.05CALL0 55183.23FALSE00
2026-01-16800CALL0 186150.73FALSE00
2026-01-16850CALL0 637159.99FALSE00
2026-01-16900CALL0 84200.32FALSE00
2026-01-16950CALL0 24205.25FALSE00
2026-01-161000CALL0 27209.88FALSE00
2026-01-161050CALL0 96214.24FALSE00
2026-01-16100PUT0 12151.93FALSE00
2026-01-16110PUT0 0167.21FALSE00
2026-01-16120.12PUT0 5155.82FALSE00
2026-01-16130PUT0 100125.43FALSE00
2026-01-16140.45PUT0 3102.32FALSE00
2026-01-16150.4PUT2 13272.72FALSE0.150.6
2026-01-16160PUT0 0140.89FALSE00
2026-01-16170.65PUT0 8267.66FALSE00
2026-01-16181.3PUT32 20476.95FALSE1.30
2026-01-16191.12PUT0 3369.01FALSE00
2026-01-16202.5PUT17 89765.42FALSE0.50.25
2026-01-16212.4PUT10 6170.43FALSE2.40
2026-01-1622.52.7PUT0 32463.34TRUE00
2026-01-16241.39PUT0 7864.6TRUE00
2026-01-16254.68PUT2 62063.66TRUE0.280.06
2026-01-16264.05PUT0 4468.23TRUE00
2026-01-16273.14PUT0 274.46TRUE00
2026-01-16285.6PUT0 33971.02TRUE00
2026-01-16290PUT0 067.61TRUE00
2026-01-16304.8PUT0 132487.61TRUE00
2026-01-16318.2PUT0 276.74TRUE00
2026-01-16320PUT0 064.75TRUE00
2026-01-16330PUT0 078.66TRUE00
2026-01-16340PUT0 071.87TRUE00
2026-01-16350PUT0 73178.23TRUE00
2026-01-16360PUT0 078.45TRUE00
2026-01-16370PUT0 084.68TRUE00
2026-01-16380PUT0 093.29TRUE00
2026-01-16390PUT0 096.33TRUE00
2026-01-16400PUT0 196.52TRUE00
2026-01-16410PUT0 093TRUE00
2026-01-16450PUT0 0103.17TRUE00
2026-01-16500PUT0 120TRUE00
2026-01-16550PUT0 230TRUE00
2026-01-16600PUT0 0133.53TRUE00
2026-01-166539.7PUT0 0141.79TRUE00
2026-01-167044.7PUT0 0149.39TRUE00
2026-01-167549.9PUT0 0156.45TRUE00
2026-01-16800PUT0 0163.04TRUE00
2026-01-16850PUT0 0169.22TRUE00
2026-01-16900PUT0 0175.03TRUE00
2026-01-16950PUT0 0180.53TRUE00
2026-01-161000PUT0 0185.74TRUE00
2026-01-161050PUT0 0190.71TRUE00
2026-04-171110.3CALL2 066.38TRUE10.30
2026-04-17120CALL0 038.89TRUE00
2026-04-17130CALL0 040.24TRUE00
2026-04-17140CALL0 071.24TRUE00
2026-04-17157CALL2 2844.25TRUE-1-0.13
2026-04-17166.76CALL2 261.92TRUE6.760
2026-04-17170CALL0 063.25TRUE00
2026-04-17184.95CALL3 30350.22TRUE-1.15-0.19
2026-04-17190CALL0 062.63TRUE00
2026-04-17204.4CALL224 1461.95TRUE-0.2-0.04
2026-04-17210CALL0 066.83TRUE00
2026-04-17222.7CALL1 3770.67FALSE-1.15-0.3
2026-04-17233.3CALL1 075.48FALSE3.30
2026-04-17242.9CALL1 270.98FALSE2.90
2026-04-17252.5CALL2 162.51FALSE2.50
2026-04-17262.4CALL0 23969.12FALSE00
2026-04-17272.9CALL0 1673.6FALSE00
2026-04-17281.75CALL2 462.45FALSE1.750
2026-04-17290CALL0 065.72FALSE00
2026-04-17301.01CALL2 454.86FALSE1.010
2026-04-17310CALL0 078.19FALSE00
2026-04-17321.2CALL2 164.98FALSE-0.75-0.38
2026-04-17331.6CALL0 867.8FALSE00
2026-04-17344.3CALL0 168.83FALSE00
2026-04-17351.88CALL0 2561.68FALSE00
2026-04-17361.6CALL0 1100.62FALSE00
2026-04-17370CALL0 0100.32FALSE00
2026-04-17380CALL0 099.86FALSE00
2026-04-17390.6CALL0 183.41FALSE00
2026-04-17402CALL0 484.34FALSE00
2026-04-17411.9CALL0 7103.55FALSE00
2026-04-17451.75CALL0 14107.2FALSE00
2026-04-17110PUT0 0160.45FALSE00
2026-04-17120PUT0 0148.71FALSE00
2026-04-17130PUT0 0139.36FALSE00
2026-04-17140PUT0 0126.51FALSE00
2026-04-17150PUT0 071.12FALSE00
2026-04-17160.5PUT0 170.75FALSE00
2026-04-17171.3PUT0 572.8FALSE00
2026-04-17182.3PUT1 30568.79FALSE0.30.15
2026-04-17190PUT0 071.34FALSE00
2026-04-17202.3PUT0 1164.33FALSE00
2026-04-17214.34PUT7 184.17FALSE4.340
2026-04-17224PUT50 767.55TRUE40
2026-04-17231.8PUT0 1274.33TRUE00
2026-04-17242.15PUT0 679.53TRUE00
2026-04-17255.5PUT0 4066TRUE00
2026-04-17264.15PUT0 268.41TRUE00
2026-04-17273.5PUT0 1867.71TRUE00
2026-04-17280PUT0 074.7TRUE00
2026-04-17297.3PUT0 174.16TRUE00
2026-04-17307.85PUT0 173.21TRUE00
2026-04-17317PUT0 272.8TRUE00
2026-04-17327.1PUT0 275.07TRUE00
2026-04-17337.3PUT0 177.16TRUE00
2026-04-17340PUT0 065.33TRUE00
2026-04-17350PUT0 063.92TRUE00
2026-04-17360PUT0 063.35TRUE00
2026-04-17370PUT0 068.81TRUE00
2026-04-17380PUT0 069.59TRUE00
2026-04-17390PUT0 062.3TRUE00
2026-04-17400PUT0 070.57TRUE00
2026-04-17410PUT0 068.6TRUE00
2026-04-17450PUT0 070.62TRUE00
2027-01-15515.1CALL0 482.08TRUE00
2027-01-151012.75CALL0 1867.35TRUE00
2027-01-15130CALL0 070.67TRUE00
2027-01-15159.05CALL0 228777.44TRUE00
2027-01-15180CALL0 066.3TRUE00
2027-01-15206CALL1 8354.28TRUE60
2027-01-15235.2CALL50 2458.46FALSE-1.2-0.19
2027-01-152510.2CALL0 7660.52FALSE00
2027-01-15288.35CALL0 756.05FALSE00
2027-01-15303.23CALL2 21857.7FALSE-0.27-0.08
2027-01-15334.1CALL0 465.75FALSE00
2027-01-15352.42CALL6 256171.83FALSE-0.08-0.03
2027-01-15370CALL0 063.83FALSE00
2027-01-15405CALL0 25272.5FALSE00
2027-01-15421.4CALL0 269057.65FALSE00
2027-01-15451.6CALL8 5062.15FALSE1.60
2027-01-15472.43CALL0 1102.3FALSE00
2027-01-15502.5CALL0 4161.14FALSE00
2027-01-15551.72CALL0 413110.45FALSE00
2027-01-1550PUT0 0594.8FALSE00
2027-01-15100.7PUT0 1171.93FALSE00
2027-01-15130PUT0 084.07FALSE00
2027-01-15151.5PUT0 20254.27FALSE00
2027-01-15180PUT0 063.25FALSE00
2027-01-15202.65PUT0 11657.7FALSE00
2027-01-15235.55PUT0 362.51TRUE00
2027-01-15255.85PUT0 37566.08TRUE00
2027-01-15286.41PUT0 563.51TRUE00
2027-01-15308.24PUT0 43263.93TRUE00
2027-01-153316.37PUT0 563.65TRUE00
2027-01-153510.48PUT0 67964.81TRUE00
2027-01-15370PUT0 060.66TRUE00
2027-01-15400PUT0 059.42TRUE00
2027-01-15420PUT0 260.89TRUE00
2027-01-15450PUT0 057.95TRUE00
2027-01-15470PUT0 059.32TRUE00
2027-01-15500PUT0 061.59TRUE00
2027-01-15550PUT0 059.79TRUE00
2028-01-211310.5CALL1 044.09TRUE10.50
2028-01-21150CALL0 065.48TRUE00
2028-01-21180CALL0 065.34TRUE00
2028-01-21207.52CALL4 571.36TRUE-1.98-0.21
2028-01-21220CALL0 061.91FALSE00
2028-01-21258.9CALL0 068.14FALSE00
2028-01-21270CALL0 060.27FALSE00
2028-01-21309.6CALL0 358.22FALSE00
2028-01-21320CALL0 059.47FALSE00
2028-01-21353.8CALL14 86152.74FALSE-0.4-0.1
2028-01-21370CALL0 055.65FALSE00
2028-01-21400CALL0 054.23FALSE00
2028-01-21450CALL0 054.88FALSE00
2028-01-21130PUT0 064.8FALSE00
2028-01-21150PUT0 062.43FALSE00
2028-01-21180PUT0 061.93FALSE00
2028-01-21200PUT0 062.88FALSE00
2028-01-21220PUT0 060.78TRUE00
2028-01-21250PUT0 060.98TRUE00
2028-01-21270PUT0 057.73TRUE00
2028-01-21300PUT0 058.16TRUE00
2028-01-21320PUT0 057.88TRUE00
2028-01-21350PUT0 056.83TRUE00
2028-01-21370PUT0 055.57TRUE00
2028-01-21400PUT0 055.18TRUE00
2028-01-21450PUT0 056.18TRUE00

Latest APLS Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST5$39.4
Jun 13, 2022 7:59 PM EST25$39.4
Jun 13, 2022 7:59 PM EST86$39.39
Jun 13, 2022 7:59 PM EST14$39.4
Jun 13, 2022 7:59 PM EST32$39.4

Apellis Pharmaceuticals, Inc (APLS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220021048/0001127602-20-021048-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000083423720004741/0000834237-20-004741-index.htm
2020-02-053/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320003295/0000899243-20-003295-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004262/0000899243-20-004262-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004264/0000899243-20-004264-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004268/0000899243-20-004268-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004275/0000899243-20-004275-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004281/0000899243-20-004281-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004288/0000899243-20-004288-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004299/0000899243-20-004299-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004303/0000899243-20-004303-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004312/0000899243-20-004312-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004314/0000899243-20-004314-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320008068/0000899243-20-008068-index.htm
2020-10-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320027595/0000899243-20-027595-index.htm
2020-10-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320027598/0000899243-20-027598-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000090221920000352/0000902219-20-000352-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000090266420001196/0000902664-20-001196-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000092963820000336/0000929638-20-000336-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220006429/0001127602-20-006429-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220011988/0001127602-20-011988-index.htm
2020-04-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220013334/0001127602-20-013334-index.htm
2020-04-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220013338/0001127602-20-013338-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220014098/0001127602-20-014098-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220014100/0001127602-20-014100-index.htm
2020-04-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220014554/0001127602-20-014554-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220016304/0001127602-20-016304-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220017178/0001127602-20-017178-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220017181/0001127602-20-017181-index.htm
2020-06-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019258/0001127602-20-019258-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019731/0001127602-20-019731-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019733/0001127602-20-019733-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019735/0001127602-20-019735-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220021048/0001127602-20-021048-index.htm
2020-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220021646/0001127602-20-021646-index.htm
2020-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220022885/0001127602-20-022885-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220023992/0001127602-20-023992-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220024043/0001127602-20-024043-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220024640/0001127602-20-024640-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220025183/0001127602-20-025183-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220026264/0001127602-20-026264-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220026748/0001127602-20-026748-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220026750/0001127602-20-026750-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220027098/0001127602-20-027098-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220027101/0001127602-20-027101-index.htm
2020-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220027991/0001127602-20-027991-index.htm
2020-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1492422/000119312520052855/0001193125-20-052855-index.htm
2020-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1492422/000119312520052867/0001193125-20-052867-index.htm
2020-04-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520098977/0001193125-20-098977-index.htm
2020-04-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1492422/000119312520115068/0001193125-20-115068-index.htm
2020-04-22DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1492422/000119312520115084/0001193125-20-115084-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520135621/0001193125-20-135621-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520141579/0001193125-20-141579-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520157384/0001193125-20-157384-index.htm
2020-10-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520277496/0001193125-20-277496-index.htm
2010-05-19DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1492242/000149224210000001/0001492242-10-000001-index.htm
2020-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1492422/000156459020007350/0001564590-20-007350-index.htm
2020-04-2910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492422/000156459020019689/0001564590-20-019689-index.htm
2020-07-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492422/000156459020034763/0001564590-20-034763-index.htm
2020-11-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492422/000156459020049423/0001564590-20-049423-index.htm
2020-08-24CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1492422/999999999720004458/9999999997-20-004458-index.htm

Apellis Pharmaceuticals, Inc (APLS) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Apellis Pharmaceuticals, Inc (APLS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 2117%
Institutional Ownership: 8285%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-02-13Pascal DeschateletsChief Operating OfficerSell55,398.0040.982,270,154.641,008,681.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-18Cedric FrancoisChief Executive OfficerSell5,000.0040.67203,330.001,027,430.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-02-18Cedric FrancoisChief Executive OfficerSell30,637.0040.661,245,792.331,032,430.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell300.0023.867,158.001,053,067.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell3,212.0022.2871,556.941,053,367.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell15,065.0021.58325,087.641,056,579.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-02-19Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,058,067.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-02-18Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,063,067.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-02-13Pascal DeschateletsChief Operating OfficerBuy117,205.002.14250,818.701,064,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-10Cedric FrancoisChief Executive OfficerBuy34,375.001,066,805.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004299/0000899243-20-004299-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell12,060.0020.69249,557.581,071,644.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-10-15Cedric FrancoisChief Executive OfficerSell5,000.0034.46172,300.001,083,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027098/0001127602-20-027098-index.htm
2020-03-17Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,083,704.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell700.0022.2915,600.201,083,704.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell2,192.0021.5747,279.251,084,404.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell2,108.0020.7343,694.621,086,596.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-09-15Cedric FrancoisChief Executive OfficerSell5,000.0030.96154,800.001,088,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220025183/0001127602-20-025183-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,088,704.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-08-20Cedric FrancoisChief Executive OfficerSell3,457.0030.00103,710.001,093,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220024043/0001127602-20-024043-index.htm
2020-08-18Cedric FrancoisChief Executive OfficerSell1,543.0030.0046,290.001,096,536.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220023992/0001127602-20-023992-index.htm
2020-07-15Cedric FrancoisChief Executive OfficerSell5,000.0032.12160,600.001,098,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220021646/0001127602-20-021646-index.htm
2020-06-15Cedric FrancoisChief Executive OfficerSell5,000.0030.21151,050.001,103,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019731/0001127602-20-019731-index.htm
2020-05-15Cedric FrancoisChief Executive OfficerSell5,000.0029.92149,600.001,108,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220017181/0001127602-20-017181-index.htm
2020-04-15Cedric FrancoisChief Executive OfficerSell5,000.0029.77148,850.001,113,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220014100/0001127602-20-014100-index.htm
2020-02-10LUKAS SCHEIBLEROfficerBuy9,375.0012,310.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004314/0000899243-20-004314-index.htm
2020-10-07Victoria L. BrownProgram Team LeadBuy12,000.0018.98227,760.0015,607.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026748/0001127602-20-026748-index.htm
2020-02-10Timothy Eugene SullivanChief Financial OfficerBuy11,688.0023,387.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004303/0000899243-20-004303-index.htm
2020-02-10Nicole D PerryVice President - FinanceBuy2,500.002,500.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004275/0000899243-20-004275-index.htm
2020-02-10Ahmad SadrOfficerBuy2,725.002,725.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004264/0000899243-20-004264-index.htm
2020-11-02Federico GrossiCHIEF MEDICAL OFFICERSell600.0031.0918,654.0027,725.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027991/0001127602-20-027991-index.htm
2020-10-01Federico GrossiOfficerSell600.0030.2218,132.0028,325.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026264/0001127602-20-026264-index.htm
2020-09-01Federico GrossiOfficerSell600.0031.5818,948.0028,925.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220024640/0001127602-20-024640-index.htm
2020-08-03Federico GrossiOfficerSell600.0026.2815,768.0029,525.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220022885/0001127602-20-022885-index.htm
2020-07-01Federico GrossiOfficerSell850.0032.4327,565.5030,125.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220021048/0001127602-20-021048-index.htm
2020-06-15Federico GrossiOfficerSell856.0030.2125,859.7630,975.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019735/0001127602-20-019735-index.htm
2020-02-10Federico GrossiOfficerBuy9,375.0031,831.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004262/0000899243-20-004262-index.htm
2020-02-10David O. WatsonGeneral CounselSell5,000.0044.50222,500.0035,417.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-10-07Victoria L. BrownProgram Team LeadSell12,000.0035.00420,000.003,607.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026748/0001127602-20-026748-index.htm
2020-02-10David O. WatsonGeneral CounselBuy6,375.0040,417.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-02-10David O. WatsonGeneral CounselBuy7,505.002.6720,038.3542,922.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-05-08PAUL R. FONTEYNEDirectorBuy5,000.0031.81159,034.005,000.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220016304/0001127602-20-016304-index.htm
2020-02-10Lucia CelonaOfficerBuy5,213.005,213.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004281/0000899243-20-004281-index.htm
2020-02-14Alec MachielsDirectorSell2,500.0042.35105,875.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006429/0001127602-20-006429-index.htm
2020-03-25Alec MachielsDirectorSell2,500.0030.0075,000.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011988/0001127602-20-011988-index.htm
2020-04-15Alec MachielsDirectorSell2,500.0030.0075,000.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220014098/0001127602-20-014098-index.htm
2020-05-15Alec MachielsDirectorSell2,500.0030.0075,000.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220017178/0001127602-20-017178-index.htm
2020-06-15Alec MachielsDirectorSell2,500.0030.2175,525.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019733/0001127602-20-019733-index.htm
2020-10-07Alec MachielsDirectorSell7,500.0035.00262,500.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026750/0001127602-20-026750-index.htm
2020-10-15Alec MachielsDirectorSell2,500.0035.0087,500.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027101/0001127602-20-027101-index.htm
2020-02-14Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006429/0001127602-20-006429-index.htm
2020-03-25Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011988/0001127602-20-011988-index.htm
2020-04-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220014098/0001127602-20-014098-index.htm
2020-05-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220017178/0001127602-20-017178-index.htm
2020-06-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019733/0001127602-20-019733-index.htm
2020-10-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027101/0001127602-20-027101-index.htm
2020-10-07Alec MachielsDirectorBuy7,500.002.6720,025.00677,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026750/0001127602-20-026750-index.htm
2020-02-10Thomas A. LacknerOfficerBuy2,725.007,725.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004268/0000899243-20-004268-index.htm
2020-02-10Pascal DeschateletsChief Operating OfficerBuy9,375.00891,118.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004312/0000899243-20-004312-index.htm
2020-02-10Adam J. TownsendOfficerBuy9,375.009,375.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004288/0000899243-20-004288-index.htm
2020-02-12Pascal DeschateletsChief Operating OfficerSell52,075.0042.802,228,966.23946,874.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-12Pascal DeschateletsChief Operating OfficerBuy117,206.002.14250,820.84998,949.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm